Sol-Gel Technologies Ltd. SLGL
Set alert
68.35 USD -0.31 -0.45%
At close · Oct 30
68.35 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
67.14 Day range 70.15
28.81 52-week range 97.97
- YTD
- +62.20%
- 1 year
- +84.73%
- Open
- 69.49
- Prev close
- 68.66
- Mkt cap
- 223.78M
- Vol
- 33.52K
- Avg vol
- 53.20K
- EPS
- -5.61
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 67.14
- High
- 70.15
- Forward P/E
- -3.44
- Beta
- 1.60
- Short ratio
- 0.59
- Inst. own
- 19.35%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 16, 2024
- 50-d avg
- 0.55476
- 200-d avg
- 0.70915
- 1y target
- 5.00
6M chart
Signals (59)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 27, 2026 | 6 days ago |
| MACD: Sell Signal | Oct 16, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| SMA: Bullish | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| RSI: Oversold | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| SMA: Bearish | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| SMA: Bearish | Aug 12, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 11, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 15, 2026 | 3 months ago |
| SMA: Bearish | Jul 10, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| SMA: Bearish | Jul 8, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| SMA: Bearish | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 24, 2026 | 4 months ago |
| SMA: Bearish | Jun 23, 2026 | 4 months ago |
| SMA: Bullish | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 16, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 16, 2026 | 4 months ago |
| SMA: Bearish | Jun 12, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| SMA: Bearish | Jun 10, 2026 | 4 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bearish | Jun 3, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 22, 2026 | 5 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 15, 2026 | 5 months ago |
| SMA: Bearish | May 14, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 7, 2026 | 5 months ago |
| MACD: Buy Signal | May 1, 2026 | 6 months ago |
Key statistics
- Market cap
- 45.97M
- Enterprise value
- -14.73M
- Trailing P/E
- 0.00
- Forward P/E
- -3.44
- PEG ratio
- 0.00
- Price / sales
- 7.01
- Price / book
- 1.19
- EPS (TTM)
- -0.34
- Beta
- 1.60
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -227.40%
- Revenue (TTM)
- 6.56M
- Revenue growth
- 814.60%
- Free cash flow
- -12.43M
- Total cash
- 30.47M
- Total debt
- 1.39M
- Return on equity
- -35.85%
- Shares outstanding
- 27.86M
- Short % of float
- 0.31%
- 50-day average
- 0.55476
- 200-day average
- 0.70915
Analyst view
Consensus: none
Price target (mean) 5.00 -92.7% downside
Now 68.35
- Target (low)
- 4.00
- Target (mean)
- 5.00
- Target (high)
- 6.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 16, 2024
Expected Aug 16, 2024. Consensus EPS estimate -0.11.
Financials — quick view
SLGL Revenue — quarterly 591.00K
SLGL Net income — quarterly -3.68M
SLGL EPS — quarterly -1.13
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 15, 2024 | Sep 1, 2024 | -0.13 | -0.01 | +0.12 | +92.31% |
| Aug 16, 2024 | Jun 1, 2024 | -0.20 | 0.07 | +0.27 | +135.00% |
| Aug 16, 2024 | Jun 1, 2024 | -0.20 | — | — | — |
| May 20, 2024 | Mar 1, 2024 | -0.15 | -0.23 | -0.08 | -53.33% |
| May 20, 2024 | Mar 1, 2024 | -0.15 | — | — | — |
| Mar 13, 2024 | Dec 1, 2023 | -0.16 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 19, 2024 | Raymond James | down | Strong Buy | Outperform |
| May 22, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 20, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 14, 2023 | HC Wainwright & Co. | main | Buy | Buy |
| Aug 11, 2023 | Raymond James | main | Strong Buy | Strong Buy |
About Sol-Gel Technologies Ltd.
Sol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat rare hyperkeratinization disorders, such as Darier, PC, PPK, Olmsted, etc. In addition, the company is also involved in the development of generic topical dermatological drug products. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- Israel
- Website
- sol-gel.com
News
- HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $110 Price Target
- This Entegris Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Cantor Fitzgerald Initiates Coverage On Sol-Gel Technologies with Overweight Rating
- Sol-Gel Technologies Q2 EPS $(1.13) Beats $(2.31) Estimate, Sales $591.000K Beat $75.000K Estimate
- HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $110 Price Target
- This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
- This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
- Mizuho Initiates Coverage On Sol-Gel Technologies with Outperform Rating, Announces Price Target of $285
- Sol-Gel Technologies Q1 EPS $(1.31) Beats $(1.84) Estimate, Sales $108.000K Miss $900.000K Estimate
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
Your note
Sign in to keep a note on SLGL — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Phoenix Holdings Ltd. | 8.87% | 2,470,192 | 4.08M | Sep 29, 2024 |
| Migdal Insurance & Financial Holdings Ltd. | 4.41% | 1,227,548 | 2.03M | Sep 29, 2024 |
| Harel Insurance Investments & Financial Services Ltd. | 3.30% | 920,333 | 1.52M | Sep 29, 2024 |
| Yelin Lapidot Holdings Management Ltd. | 0.82% | 229,178 | 378.14K | Sep 29, 2024 |
| Prosperity Wealth Management, Inc. | 0.59% | 163,400 | 269.61K | Sep 29, 2024 |
| Raymond James Financial Services Advisors, Inc. | 0.32% | 88,461 | 145.96K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity NASDAQ Composite Index Fund | 0.05% | 13,406 | 22.12K | Oct 30, 2024 |